When was DATWYLER PHARMA PACKAGING BELGIUM founded?

DATWYLER PHARMA PACKAGING BELGIUM was founded on 16 Aug 1989, making it 37 years old.

Is DATWYLER PHARMA PACKAGING BELGIUM still active?

Yes, DATWYLER PHARMA PACKAGING BELGIUM is currently active.

What does DATWYLER PHARMA PACKAGING BELGIUM do?

DATWYLER PHARMA PACKAGING BELGIUM's registered main activities are Manufacture of other rubber products and Manufacture of semi-finished plastic products: plates, sheets, blocks, film, foil, strips, etc..

Where is DATWYLER PHARMA PACKAGING BELGIUM registered?

DATWYLER PHARMA PACKAGING BELGIUM's registered address is Industrieterrein Kolmen 1519, 3570 Alken, Belgium.

How many employees does DATWYLER PHARMA PACKAGING BELGIUM have?

Based on its most recently filed annual accounts (fiscal year ending 31 Dec 2025), DATWYLER PHARMA PACKAGING BELGIUM reported 665.6 full-time equivalent employees.

What is DATWYLER PHARMA PACKAGING BELGIUM's annual turnover?

DATWYLER PHARMA PACKAGING BELGIUM's most recently filed annual turnover (fiscal year ending 31 Dec 2025) was €190,135,940.

Did DATWYLER PHARMA PACKAGING BELGIUM make a profit or a loss?

DATWYLER PHARMA PACKAGING BELGIUM's most recently filed annual accounts (fiscal year ending 31 Dec 2025) reported a profit of €53,689,748.

When did DATWYLER PHARMA PACKAGING BELGIUM last file annual accounts?

DATWYLER PHARMA PACKAGING BELGIUM's most recently filed annual accounts cover the fiscal year ending 31 Dec 2025.

Is DATWYLER PHARMA PACKAGING BELGIUM B Corp certified?

We have no B Corp certification on file for DATWYLER PHARMA PACKAGING BELGIUM.

Does DATWYLER PHARMA PACKAGING BELGIUM hold Fairtrade certification?

No, DATWYLER PHARMA PACKAGING BELGIUM does not currently hold Fairtrade certification.

DATWYLER PHARMA PACKAGING BELGIUM

BE 0438.160.084

Copied!

NV/SA

Status

Active

Founded

16 Aug 1989 · 37 yrs

Size

Large · 665.6 FTE

Abbreviation

DPP BELGIUM

Main activity

Manufacture of other rubber products

Activities

2 activities

Manufacture of other rubber productsManufacture of semi-finished plastic products: plates, sheets, blocks, film, foil, strips, etc.

Financials

Turnover2025

€190M+8.8%

Profit / Loss2025

€53.7M+163.3%

Equity2025

€73.7M+22.5%

2025	2024	2023	2022
€190,135,940+8.8%	€174,794,955-11.1%	€196,562,157-0.2%	€196,916,614
€53,689,748+163.3%	-€84,794,232-315%	€39,436,006-9.2%	€43,421,694
€73,666,848+22.5%	€60,116,957-58.4%	€144,658,073-0.4%	€145,316,647
€137,524,252-5.2%	€145,102,795+28.6%	€112,873,933-5.6%	€119,628,020
€2,517,803+83.5%	€1,372,143-28.8%	€1,927,448-15.1%	€2,270,878
665.6-1.7%	676.9-3.8%	704+0.3%	702
€285,661+10.6%	€258,229-7.5%	€279,208-0.5%	€280,508

Frequently asked questions

01What is DATWYLER PHARMA PACKAGING BELGIUM's official registered name?

DATWYLER PHARMA PACKAGING BELGIUM.

02What is DATWYLER PHARMA PACKAGING BELGIUM's enterprise number (VAT number)?

BE 0438.160.084.

03What is DATWYLER PHARMA PACKAGING BELGIUM's legal form?

Naamloze vennootschap (NV) / Société anonyme (SA).

Sources

KBO — Kruispuntbank van Ondernemingen

NBB — Nationale Bank van België

Links

Belgian National Gazette — Publications

Check withholding obligation

Central Register of Director Disqualifications

	2025	2024	2023	2022
Income statement
	€190,135,940+8.8%	€174,794,955-11.1%	€196,562,157-0.2%	€196,916,614
	€66,886,900+5.4%	€63,453,080+0.4%	€63,187,760+6.4%	€59,373,220
	€43,821,916+25.5%	€34,908,353-24.7%	€46,378,691-20.5%	€58,323,284
	€56,408,068+19.7%	€47,116,884-20.7%	€59,391,583-15.8%	€70,525,443
	€66,169,258+191.8%	-€72,116,255-238.2%	€52,196,227-6.2%	€55,632,876
	€53,689,748+163.3%	-€84,794,232-315%	€39,436,006-9.2%	€43,421,694
	€1,089,217+12.9%	€964,879-69.3%	€3,142,884+33.1%	€2,361,543
Profitability
	29.7%+10.1%	27.0%-10.8%	30.2%-15.6%	35.8%
	28.2%+158.2%	-48.5%-341.8%	20.1%-9%	22.1%
	72.9%+151.7%	-141.0%-617.4%	27.3%-8.8%	29.9%
	25.3%+161.6%	-41.0%-369%	15.3%-6.5%	16.3%
Solvency
	€212,428,827+2.8%	€206,564,122-20.1%	€258,406,930-2.9%	€266,072,262
	€50,597,366-5.6%	€53,614,611-5.8%	€56,930,641-7.1%	€61,278,229
	€66,069,895-0.1%	€66,120,534-46.7%	€124,159,441+4.8%	€118,500,009
	€73,666,848+22.5%	€60,116,957-58.4%	€144,658,073-0.4%	€145,316,647
	34.7%+19.2%	29.1%-48%	56.0%+2.5%	54.6%
	€63,000,000-43%	€110,500,000+190.8%	€38,000,0000%	€38,000,000
	0.86-53.5%	1.84+599.7%	0.26+0.5%	0.26
	€137,524,252-5.2%	€145,102,795+28.6%	€112,873,933-5.6%	€119,628,020
	1.87-22.7%	2.41+209.3%	0.78-5.2%	0.82
	13.87+16.8%	11.88-85%	79.21-29.5%	112.37
Liquidity
	€2,517,803+83.5%	€1,372,143-28.8%	€1,927,448-15.1%	€2,270,878
	€20,570,013+11.9%	€18,376,835-14.6%	€21,521,040-9.2%	€23,700,255
	€37,085,695+7.1%	€34,634,501-11.3%	€39,059,238-5.7%	€41,402,508
	€20,038,928-10.5%	€22,392,721+6.8%	€20,965,278-6.3%	€22,373,355
	€70,914,274+123.6%	€31,716,601-56.5%	€72,991,208-8.9%	€80,159,853
	1.18-49.8%	2.34+143.3%	0.96-2.9%	0.99
	€15,773,025-67.1%	€47,889,830>1000%	-€807,132-149.8%	€1,622,145
Efficiency
	71 days-1.6%	72 days-0.3%	73 days-5.5%	77 days
	70 days-18.8%	86 days+24%	69 days-2.3%	71 days
	189 days+11.6%	169 days+5.4%	160 days-7.2%	173 days
	2.04+2.5%	1.99-8.3%	2.17-11.4%	2.45
Profit appropriation
	€40,000,000	—	€40,000,000-16.7%	€48,000,000
	€4,414,3360%	€4,414,3360%	€4,414,3360%	€4,414,336
	€50,786,327+36.9%	€37,096,579-69.6%	€121,890,811-0.5%	€122,454,805

Sources

NBB — Nationale Bank van België

	2025	2024	2023	2022
Income statement
	€190,135,940+8.8%	€174,794,955-11.1%	€196,562,157-0.2%	€196,916,614
	€66,886,900+5.4%	€63,453,080+0.4%	€63,187,760+6.4%	€59,373,220
	€43,821,916+25.5%	€34,908,353-24.7%	€46,378,691-20.5%	€58,323,284
	€56,408,068+19.7%	€47,116,884-20.7%	€59,391,583-15.8%	€70,525,443
	€66,169,258+191.8%	-€72,116,255-238.2%	€52,196,227-6.2%	€55,632,876
	€53,689,748+163.3%	-€84,794,232-315%	€39,436,006-9.2%	€43,421,694
	€1,089,217+12.9%	€964,879-69.3%	€3,142,884+33.1%	€2,361,543
Profitability
	29.7%+10.1%	27.0%-10.8%	30.2%-15.6%	35.8%
	28.2%+158.2%	-48.5%-341.8%	20.1%-9%	22.1%
	72.9%+151.7%	-141.0%-617.4%	27.3%-8.8%	29.9%
	25.3%+161.6%	-41.0%-369%	15.3%-6.5%	16.3%
Solvency
	€212,428,827+2.8%	€206,564,122-20.1%	€258,406,930-2.9%	€266,072,262
	€50,597,366-5.6%	€53,614,611-5.8%	€56,930,641-7.1%	€61,278,229
	€66,069,895-0.1%	€66,120,534-46.7%	€124,159,441+4.8%	€118,500,009
	€73,666,848+22.5%	€60,116,957-58.4%	€144,658,073-0.4%	€145,316,647
	34.7%+19.2%	29.1%-48%	56.0%+2.5%	54.6%
	€63,000,000-43%	€110,500,000+190.8%	€38,000,0000%	€38,000,000
	0.86-53.5%	1.84+599.7%	0.26+0.5%	0.26
	€137,524,252-5.2%	€145,102,795+28.6%	€112,873,933-5.6%	€119,628,020
	1.87-22.7%	2.41+209.3%	0.78-5.2%	0.82
	13.87+16.8%	11.88-85%	79.21-29.5%	112.37
Liquidity
	€2,517,803+83.5%	€1,372,143-28.8%	€1,927,448-15.1%	€2,270,878
	€20,570,013+11.9%	€18,376,835-14.6%	€21,521,040-9.2%	€23,700,255
	€37,085,695+7.1%	€34,634,501-11.3%	€39,059,238-5.7%	€41,402,508
	€20,038,928-10.5%	€22,392,721+6.8%	€20,965,278-6.3%	€22,373,355
	€70,914,274+123.6%	€31,716,601-56.5%	€72,991,208-8.9%	€80,159,853
	1.18-49.8%	2.34+143.3%	0.96-2.9%	0.99
	€15,773,025-67.1%	€47,889,830>1000%	-€807,132-149.8%	€1,622,145
Efficiency
	71 days-1.6%	72 days-0.3%	73 days-5.5%	77 days
	70 days-18.8%	86 days+24%	69 days-2.3%	71 days
	189 days+11.6%	169 days+5.4%	160 days-7.2%	173 days
	2.04+2.5%	1.99-8.3%	2.17-11.4%	2.45
Profit appropriation
	€40,000,000	—	€40,000,000-16.7%	€48,000,000
	€4,414,3360%	€4,414,3360%	€4,414,3360%	€4,414,336
	€50,786,327+36.9%	€37,096,579-69.6%	€121,890,811-0.5%	€122,454,805

2025

2024

2023

2022

Income statement

€190,135,940+8.8%

€174,794,955-11.1%

€196,562,157-0.2%

€196,916,614

€66,886,900+5.4%

€63,453,080+0.4%

€63,187,760+6.4%

€59,373,220

€43,821,916+25.5%

€34,908,353-24.7%

€46,378,691-20.5%

€58,323,284

€56,408,068+19.7%

€47,116,884-20.7%

€59,391,583-15.8%

€70,525,443

€66,169,258+191.8%

-€72,116,255-238.2%

€52,196,227-6.2%

€55,632,876

€53,689,748+163.3%

-€84,794,232-315%

€39,436,006-9.2%

€43,421,694

€1,089,217+12.9%

€964,879-69.3%

€3,142,884+33.1%

€2,361,543

Profitability

29.7%+10.1%

27.0%-10.8%

30.2%-15.6%

35.8%

28.2%+158.2%

-48.5%-341.8%

20.1%-9%

22.1%

72.9%+151.7%

-141.0%-617.4%

27.3%-8.8%

29.9%

25.3%+161.6%

-41.0%-369%

15.3%-6.5%

16.3%

Solvency

€212,428,827+2.8%

€206,564,122-20.1%

€258,406,930-2.9%

€266,072,262

€50,597,366-5.6%

€53,614,611-5.8%

€56,930,641-7.1%

€61,278,229

€66,069,895-0.1%

€66,120,534-46.7%

€124,159,441+4.8%

€118,500,009

€73,666,848+22.5%

€60,116,957-58.4%

€144,658,073-0.4%

€145,316,647

34.7%+19.2%

29.1%-48%

56.0%+2.5%

54.6%

€63,000,000-43%

€110,500,000+190.8%

€38,000,0000%

€38,000,000

0.86-53.5%

1.84+599.7%

0.26+0.5%

0.26

€137,524,252-5.2%

€145,102,795+28.6%

€112,873,933-5.6%

€119,628,020

1.87-22.7%

2.41+209.3%

0.78-5.2%

0.82

13.87+16.8%

11.88-85%

79.21-29.5%

112.37

Liquidity

€2,517,803+83.5%

€1,372,143-28.8%

€1,927,448-15.1%

€2,270,878

€20,570,013+11.9%

€18,376,835-14.6%

€21,521,040-9.2%

€23,700,255

€37,085,695+7.1%

€34,634,501-11.3%

€39,059,238-5.7%

€41,402,508

€20,038,928-10.5%

€22,392,721+6.8%

€20,965,278-6.3%

€22,373,355

€70,914,274+123.6%

€31,716,601-56.5%

€72,991,208-8.9%

€80,159,853

1.18-49.8%

2.34+143.3%

0.96-2.9%

0.99

€15,773,025-67.1%

€47,889,830>1000%

-€807,132-149.8%

€1,622,145

Efficiency

71 days-1.6%

72 days-0.3%

73 days-5.5%

77 days

70 days-18.8%

86 days+24%

69 days-2.3%

71 days

189 days+11.6%

169 days+5.4%

160 days-7.2%

173 days

2.04+2.5%

1.99-8.3%

2.17-11.4%

2.45

Profit appropriation

€40,000,000

—

€40,000,000-16.7%

€48,000,000

€4,414,3360%

€4,414,336

€50,786,327+36.9%

€37,096,579-69.6%

€121,890,811-0.5%

€122,454,805

DATWYLER PHARMA PACKAGING BELGIUM

Activities

Financials

Frequently asked questions

All locations

All locations